Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
BADG September 2014: Session Abstract
Share |


Achieving a More Objective Assessment of Attribute and Parameter Criticality

 Presented by Patrick Swann, Biogen Idec

The identification of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) is a regulatory expectation.  However, there are no uniform/harmonized approaches or criteria that can be used to distinguish “critical” from “non-critical” for either quality attributes or process parameters.  Absent such criteria, the identification of CQAs and CPPs is susceptible to individual subjectivity and preference.  This subjectivity can result in a lack of regulatory predictability, disharmony and puts at risk potential benefits of platform manufacturing.  This presentation is intended to support a proposal that an explicit linkage between CQAs/CPPs and regulatory commitments (registered process description and control elements with associated regulatory lifecycle change management implications) can be leveraged to make the identification of criticality more objective and predictable.




more Calendar

7/10/2018 » 7/12/2018
Cell & Gene Therapy 2018

7/16/2018 » 7/17/2018
CMC Strategy Forum Summer 2018

Featured Members
Linda O. Narhi, Amgen Inc.Visit the CASSS News page to get to know Linda Narhi!

Membership Software Powered by YourMembership  ::  Legal